ArticleNaunyn-Schmiedeberg's archives of pharmacology2006

The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.

Pascal Guerard et al.PubMed ↗Publisher ↗

No numbers read from the abstract.